Medical Services Expenditures per Capita by Disease: Infectious and Parasitic Diseases, Blended Account Basis (INFAPSPCBLEND) | FRED | St. Louis Fed
- Rows
- 22
- Columns
- 2
- Data range
- 2000-01-01 to 2021-01-01
Graph and download economic data for Medical Services Expenditures per Capita by Disease: Infectious and Parasitic Diseases, Blended Account Basis (INFAPSPCBLEND) from 2000 to 2021 about infection, disease, healthcare, medical, health, expenditures, per capita, services, and USA.
AI analysis
Analysis: Medical Services Expenditures per Capita — Infectious and Parasitic Diseases
1. Dataset Overview and Value
This series (INFAPSPCBLEND) tracks annual per-capita medical services expenditures attributable to infectious and parasitic diseases in the U.S., spanning 2000–2021 on a "blended account basis" — a FRED-specific methodology that typically combines multiple national health expenditure accounts to produce a more comprehensive per-capita estimate. The data is sourced directly from the St. Louis Fed's FRED API (fredgraph.csv), a highly reliable and frequently-updated public data platform, meaning the series carries strong institutional credibility. Given its annual granularity and 22-year span, this dataset is well-suited for longitudinal correlation studies — particularly examining how infectious disease spending trends relate to public health events (e.g., HIV/AIDS treatment evolution, H1N1, COVID-19 in 2020-2021), insurance coverage expansions (ACA in 2010), or broader healthcare cost inflation.
2. Data Quality Observations
The dataset is clean by conventional null/completeness metrics: zero null cells across both columns, and both columns show full distinct-value counts (22 distinct values for 22 rows), indicating no repeated timestamps or expenditure values — a good sign against accidental duplication. However, the "Duplicate rows" field is marked as pending Phase D recomputation, so duplication status isn't fully confirmed yet. Additionally, the sample data rows are not yet populated, limiting the ability to spot-check formatting, unit consistency, or anomalous entries directly — this should be resolved before finalizing quality sign-off.
3. Key Column Distributions
The observationdate column is a clean, fully-distinct annual time index with no gaps (0 nulls, 22 distinct dates) — ideal as a join key. The expenditure column (INFAPSPCBLEND) shows a mean of $256.34 and median of $216.77, with the mean exceeding the median — consistent with the reported right-skew (skewness = 1.54). This suggests expenditures were low and stable for much of the early series before accelerating sharply in later years (min $87.47, max $697.52 — nearly an 8x range). The interquartile range ($138.51–$327.27) captures the bulk of "normal" years, while 2 outliers (likely 2020–2021, coinciding with COVID-19) pull the distribution's tail upward. This pattern strongly suggests a structural break or inflection point rather than gradual linear growth.
4. Recommended Join Keys
observationdate is the clear and only viable join key — it's a clean annual date field with zero nulls and full distinctness. For cross-dataset correlation, this should be aligned to year-level granularity (extracting year from timestamp) since the data is annual (January 1 of each year), enabling joins with other annual economic or health indicators. Analysts should confirm counterpart datasets use calendar-year or fiscal-year alignment to avoid temporal mismatch.
5. Suggested Pairings for Correlation Analysis
Strong candidates include: (a) other FRED health expenditure series by disease category (e.g., circulatory, respiratory, neoplasms) to compare relative growth rates and identify whether infectious disease spending outpaced other categories, especially 2020-2021; (b) CDC/WHO infectious disease incidence and mortality rates to test whether spending correlates with case burden or lags behind outbreaks; (c) health insurance coverage rates (e.g., FRED's uninsured rate series) to explore access-driven spending changes; (d) CPI for medical care services to distinguish real cost growth from price inflation; and (e) federal public health funding/appropriations data to assess policy-driven spending shifts, particularly around the ACA (2010) and COVID-19 relief acts (2020-2021).
Columns
- observation_date (date)
- INFAPSPCBLEND (decimal)